Search - tctmd.com

Displaying 521 - 540 of 4671

Sort: Relevancy | Date

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

News Features

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

March 29, 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

ACC Chest Pain Pathway Performs Well Overall, Less So for Those With CAD

News Daily News

ACC Chest Pain Pathway Performs Well Overall, Less So for Those With CAD

Yael L. Maxwell

March 28, 2024

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

News Conference News CRT 2024

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

March 19, 2024

Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime

News Daily News

Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime

Yael L. Maxwell

March 18, 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

Patients With CKD Remain Underrepresented in Trials of CV Meds

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

March 08, 2024

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

News Daily News

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Yael L. Maxwell

March 07, 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Micra Leadless Pacemaker Performs Well Through 5 Years

News Daily News

Micra Leadless Pacemaker Performs Well Through 5 Years

March 06, 2024

Semaglutide Winning Streak Continues in CKD With FLOW

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

March 06, 2024

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Presentation THT 2024

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Presenter: Lucas Zier

March 06, 2024

Debating the Role of T-TEER in the Sickest Patients

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

Cannabis Use Tied to Greater Risks of MI, Stroke in a Large Study

News Daily News

Cannabis Use Tied to Greater Risks of MI, Stroke in a Large Study

February 28, 2024

‘Landmark Moment’ for Middle Meningeal Artery Embolization for Subdural Hematoma

News Conference News ISC 2024

‘Landmark Moment’ for Middle Meningeal Artery Embolization for Subdural Hematoma

February 16, 2024

PCI Radiation Reduction Intervention Scores Big in Michigan

News Daily News

PCI Radiation Reduction Intervention Scores Big in Michigan

February 15, 2024

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

News Daily News

AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis

February 14, 2024

TriClip panel FDA

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.